The interaction of S100A3 with RARα is observed in breast cancer and lung cancer, acute-myeloid-leukemia (AML) as well as acute promyelocytic leukemia (APL) cells, in which S100A3 binds also to PML-RARα. Here, S100A3 is linked to breast carcinoma.